Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Enterprise Value (2022 - 2026)

HeartSciences (HSCS) has disclosed Enterprise Value for 4 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 51.85% year-over-year to -$2.0 million, compared with a TTM value of -$2.0 million through Oct 2025, up 51.85%, and an annual FY2025 reading of -$1.1 million, up 81.09% over the prior year.
  • Enterprise Value was -$2.0 million for Q4 2025 at HeartSciences, up from -$2.8 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$100144.0 in Q4 2023 and bottomed at -$7.1 million in Q1 2024.
  • Average Enterprise Value over 4 years is -$2.8 million, with a median of -$2.6 million recorded in 2025.
  • The sharpest move saw Enterprise Value surged 96.74% in 2023, then crashed 3946.29% in 2024.
  • Year by year, Enterprise Value stood at -$3.1 million in 2022, then soared by 96.74% to -$100144.0 in 2023, then plummeted by 3946.29% to -$4.1 million in 2024, then soared by 51.85% to -$2.0 million in 2025.
  • Business Quant data shows Enterprise Value for HSCS at -$2.0 million in Q4 2025, -$2.8 million in Q3 2025, and -$1.1 million in Q2 2025.